Delivery Order SPE2DB25D7056-SPE2DB25FTMHG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cephalexin 250 mg/5 mL suspension in 100 mL quantities, with a ceiling value of $4,224.34. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on November 17, 2025, with a ceiling value of $1,121.86 and an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,809.28 to AmerisourceBergen Drug Corp for Cephalexin 250 mg/5 ml suspension in 100 ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. Performance will be completed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 3, 2026, for the supply of Cephalexin 250 mg/5 mL suspension in 100 mL quantities, with a ceiling value of $9,689.94. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through competitive procurement with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cephalexin 100ml, with a contract ceiling value of $3,361.64 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,389.03 to AmerisourceBergen Drug Corp for the supply of Cephalexin 250 mg/5 mL suspension in 100 mL quantities. This award was made on July 29, 2025, under a firm fixed-price contract type with an ultimate completion date of July 30, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Cephalexin is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.75 to AmerisourceBergen Drug Corp for Cephalexin 250 mg/5 mL suspension in 100 mL quantities. This award, issued on November 3, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and carries no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Cephalexin 250 mg capsules in quantities of 500 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,456.96 and is scheduled for completion by August 11, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,789.64, is for the delivery of 4,563,942,071 units of the pharmaceutical product Cephalexin 250 mg/5 ml suspension in 100 ml containers. This delivery order does not have a set-aside designation. The award is part of a larger, single-award indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,567,127,671 units of Cephalexin 250 mg/5 ml suspension in 100 ml containers with a ceiling value of $1,362.50. The contract has an ultimate completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMHGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities, with a ceiling value of $27,376.80. This is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025, to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting open competition among qualified vendors. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support platform enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. The Cephalexin order supports federal medical procurement needs for the Defense Health Agency and other government healthcare systems served under the prime IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 5/2/25 |